The burgeoning field of peptidic therapeutics represents a significant paradigm shift in how we manage disease and improve bodily performance. Differing from traditional small molecules, short-chain proteins offer remarkable selectivity, often interacting with specific receptors or enzymes with superior accuracy. This focused action reduces off-tar